Related Experiment Video
Updated: Mar 15, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Foot burns and diabetes: a retrospective study
E Lawrence1, F Li1
1Concord Hospital Burns Unit, Rhodes, Australia.
Patients with diabetes experiencing foot burns face significantly longer hospital stays and higher amputation rates. This highlights the need for targeted burn prevention education for this vulnerable population.
Area of Science:
- Medical Research
- Clinical Outcomes
- Burn Management
Background:
- Diabetes mellitus complicates wound healing, particularly in foot burn cases.
- The specific impact of diabetes on foot burn patient outcomes remains under-examined.
Purpose of the Study:
- To investigate and compare the clinical outcomes of patients with foot burns, differentiating between those with and without diabetes.
- To identify specific challenges and adverse events associated with diabetes in foot burn patients.
Main Methods:
- A retrospective audit of 33 patients with foot burns (15 with diabetes, 18 without) admitted to Concord Hospital Burns Unit between 2012-2013.
- Patients were matched for percentage total body surface area of burns to ensure comparable injury severity.
Main Results:
- Diabetic patients had significantly longer inpatient (21.27 vs 9.61 days) and total (64.80 vs 30.56 days) lengths of stay.
- Higher rates of regrafting (20% vs 5.55%) and amputations (33.33% vs 0%) were observed in the diabetic group.
- Diabetic patients were older (56.60 vs 39.44 years) and less likely to be prescribed pressure garments (13.33% vs 50.00%).
Conclusions:
- Diabetes is associated with poorer outcomes in foot burn patients, including prolonged healing and increased surgical interventions.
- There is a critical need for enhanced burn prevention strategies and education tailored to individuals with diabetes.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Peripheral Artery Disease IV: Nursing Management
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

